Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

SAMSUNG PHARMACEUTICAL.CO.,Ltd. (001360) Stock Price & Analysis

001360 Stock Chart & Stats

₩1,203.00-₩27.00(-2.20%)
At close: 3:30 PM GMT+9
KRW 1,200KRW 1,300KRW 1,4003 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
KRW 1,190.00 - KRW 1,230.00
52-Week Range
KRW 1,140.00 - KRW 2,320.00
Previous Close
KRW 1,230.00
Volume
N/A
Average Volume (3M)
333.71K
Market Cap
KRW 113.23B
Enterprise Value
KRW 134.50B
Total Cash (Recent Filing)
KRW 9.56B
Total Debt (Recent Filing)
KRW 18.60B
Price to Earnings (P/E)
―
Beta
0.26
Next Earnings
Nov 18, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Moderate Leverage

Moderate leverage provides a comparatively sound solvency base and limits immediate dependence on debt financing. This gives Samsung Pharmaceutical greater flexibility to manage its operations and pursue improvements while reducing the balance-sheet strain that can accompany heavier borrowing.

Established Pharmaceutical Portfolio

Participation across OTC, prescription, and related healthcare products gives the company an established pharmaceutical platform rather than reliance on a single product category. Distribution through medical and retail channels can support broader customer access and recurring commercial opportunities.

Gross Margin Base

A gross margin near 39% indicates that the products retain meaningful economic value before operating costs are deducted. If management can improve cost discipline and operating efficiency, this existing gross-profit base could provide a foundation for restoring positive operating earnings over time.

Bears Say

Persistent Cash Burn

Persistent negative operating and free cash flow shows that the core business is not currently funding itself. Continued cash burn can increase reliance on external funding or existing balance-sheet resources, reducing financial flexibility and raising risk if operating losses continue.

Weak Profitability

The combination of declining revenue, a large net loss, and deeply negative operating margins points to weak earnings power rather than a temporary margin squeeze alone. Without a sustained improvement in operating profitability, the company may struggle to convert its product base into durable shareholder returns.

Earnings Volatility

The sharp reversal from annual profit to sizable TTM losses demonstrates limited earnings consistency. Volatile results make planning and capital allocation more difficult, while deeply negative returns on equity indicate that the existing capital base is currently producing poor economic returns.

001360 FAQ

What was SAMSUNG PHARMACEUTICAL.CO.,Ltd.’s price range in the past 12 months?
SAMSUNG PHARMACEUTICAL.CO.,Ltd. lowest stock price was ₩1140.00 and its highest was ₩2320.00 in the past 12 months.
What is SAMSUNG PHARMACEUTICAL.CO.,Ltd.’s market cap?
SAMSUNG PHARMACEUTICAL.CO.,Ltd.’s market cap is ₩113.23B.
When is SAMSUNG PHARMACEUTICAL.CO.,Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SAMSUNG PHARMACEUTICAL.CO.,Ltd.’s earnings last quarter?
SAMSUNG PHARMACEUTICAL.CO.,Ltd. released its earnings results on Aug 14, 2026. The company reported -₩601.844 earnings per share for the quarter.
Is SAMSUNG PHARMACEUTICAL.CO.,Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does SAMSUNG PHARMACEUTICAL.CO.,Ltd. pay dividends?
SAMSUNG PHARMACEUTICAL.CO.,Ltd. does not currently pay dividends.
What is SAMSUNG PHARMACEUTICAL.CO.,Ltd.’s EPS estimate?
SAMSUNG PHARMACEUTICAL.CO.,Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SAMSUNG PHARMACEUTICAL.CO.,Ltd. have?
SAMSUNG PHARMACEUTICAL.CO.,Ltd. has 94,162,080 shares outstanding.
What happened to SAMSUNG PHARMACEUTICAL.CO.,Ltd.’s price movement after its last earnings report?
SAMSUNG PHARMACEUTICAL.CO.,Ltd. reported an EPS of -₩601.844 in its last earnings report. Following the earnings report the stock price went up 0.849%.
Which hedge fund is a major shareholder of SAMSUNG PHARMACEUTICAL.CO.,Ltd.?
Currently, no hedge funds are holding shares in KR:001360
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology